Trinity Biotech (TRIB) Times Interest Earned (2009 - 2024)

Trinity Biotech has disclosed Times Interest Earned across 16 years of filings, most recently posting $3.41 for Q4 2024.

• Times Interest Earned for Q4 2024 came in at $3.41, up 110.58% year-over-year; the trailing twelve-month figure through Dec 2024 was $2.21 (down 9.22% YoY), and the FY2025 annual result was -$0.74, up 66.64% from the prior year.
• Times Interest Earned came in at $3.41 for Q4 2024 at Trinity Biotech, up from $0.83 in the prior quarter.
• In the past five years, Times Interest Earned ranged from a high of $159.82 in Q2 2021 to a low of -$222.89 in Q2 2022.
• The 5-year median for Times Interest Earned is $1.13 (2024), against an average of -$2.56.
• Across the five-year window, Times Interest Earned tumbled 587.72% in 2020 and jumped 39051.13% in 2021, its largest moves.
• Trinity Biotech's Times Interest Earned stood at -$7.41 in 2020, then jumped by 97.47% to -$0.19 in 2021, then jumped by 1923.82% to $3.42 in 2022, then plunged by 52.74% to $1.62 in 2023, then soared by 110.58% to $3.41 in 2024.
• The last three Times Interest Earned figures came in at $3.41 (Q4 2024), $0.83 (Q3 2024), and $1.43 (Q2 2024), per Business Quant data.